Hamdy Abdelwahab accepted a two-year suspension from the United States Anti-Doping Agency (USADA) for two violations stemming from his UFC debut.
USADA announced on Friday the UFC heavyweight tested positive for the anabolic agent methenolone and its metabolites twice, once in an in-competition sample on July 30 and once in an out-of-competition sample on August 27. Abdelwahab was not notified of his first positive test, so the agency combined that and his second positive test into a single violation.
The second violation was for ‘tampering,’ as the Egyptian fighter did not declare his methenolone use before his UFC debut.